Respiratorius is a research company. Today, the company is mainly focused on development of new drug candidates for the treatment of chronic obstructive pulmonary disease (COPD), asthma and cancer. Additionally, the company focuses on project development in the area of cardiovascular diseases. The company was formed in 1999 as a spin-off from Lund University. The company is based in Lund.

Quotes for Respiratorius AB

Right Now

+/-
0.04
%
3,33%
Latest
1.24
High
1.246
Low
1.172
Volume
76 443
Turnover (SEK)
93 117
Value (MSEK)
265,2

Board

CEO

  • Johan Drott

Chairperson of the Board

  • Niklas Prager

Board

  • Anna Törner
  • Ingemar Kihlström
  • Kristina Drott
  • Peter Buhl

Videos